Sarasota, FL -- (SBWire) -- 03/06/2019 --Zion Market Research has published a new report titled "Genotyping Assay Market by Products & Services (Reagents & Kits, Genotyping Services, Instruments, and Bioinformatics), by Technology (PCR, Microarrays, Sequencing, Capillary Electrophoresis, MALDI-Tof MS, and Others), by Application (Pharmacogenomics, Diagnostics & Personalized Medicine, Animal Genetics, Agricultural Biotechnology, and Others), and by End-User (Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Research Laboratories, Academic Institutes, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025". According to the report, the global genotyping assay market was valued at approximately USD 11.9 billion in 2018 and is expected to generate around USD 46.9 billion by 2025, at a CAGR of around 21.8% between 2019 and 2025.
Download Free PDF Research Report Brochure @ https://www.zionmarketresearch.com/requestbrochure/genotyping-assay-market
Genotyping is a technology used to identify genetic variation in the genomic sequence or allelic genes of an individual by comparing it against the reference sequence. Genotyping helps to explore genetic variants including structural changes in DNA and single nucleotide polymorphism (SNPs). The increasing prevalence of genetic disorders worldwide, decreasing cost of DNA sequencing, technological advancements in the field of genotyping, and growing use of genotyping for drug development are the major factors contributing toward the genotyping assay market globally. Additionally, the escalating demand for bioinformatics in drug discovery and data analysis, burgeoning popularity of personalized medicine, and increasing awareness about genotyping assay will further propel this market's growth. Other factors anticipated to fuel the global genotyping assay market are increasing the need for rapid genotyping-based diagnostics tests and the rising number of increasing plant and animal genotyping research activities. However, the high cost of equipment used in genotyping assays may hamper the market growth in the future. Growing genotyping and sequencing research and development activities and massive demand for plant and animal genome analysis are to generate new growth opportunities for the genotyping assay market over the upcoming years.
The global genotyping assay market segments are divided into products and services, technology, application, and end-user. Based on products and services, the market is segmented into genotyping services, reagents and kits, instruments and bioinformatics. The reagents and kits segment held the largest market share in 2018, owing to the large-scale use of reagents and kits for a wide range of genotyping applications, such as drug efficacy and safety assessment, animals and plants breed development and improvement, personalizing chronic disease treatment etc. Instruments are further segmented into sequencers and amplifiers and analyzers. Bioinformatics sub-segment includes software and services.
By technology, the market is segmented into microarrays, polymerase chain reaction (PCR), sequencing, capillary electrophoresis, matrix-assisted laser desorption/ionization-time of flight (MALDI-Tof) mass spectrometry, and others. Sequencing segment held the largest market share in 2018, due to technological advancements, decreasing the cost of sequencing, and increasing use of DNA sequencing technologies for various applications. Polymerase chain reaction (PCR) is further segmented into real-time PCR and digital PCR. Sequencing segment is further split into next-generation sequencing, pyrosequencing, and Sanger sequencing. Capillary electrophoresis technology segment is further split into amplified fragment length polymorphism (AFLP), restriction fragment length polymorphism (RFLP), and single-strand conformation polymorphism.
Based on application, the market is split into pharmacogenomics, diagnostics and personalized medicine, animal genetics, agricultural biotechnology, and others. Pharmacogenomics dominated the global market in 2018. The growing adoption of the genotyping assay is anticipated to drive the demand for diagnostics and personalized medicine in the future.
Pharmaceutical and biopharmaceutical companies, diagnostic and research laboratories, academic institutes, and others form the end-user segment of the market. Pharmaceutical and biopharmaceutical companies are expected to register the highest growth rate over the forecast time period.
By region, North America led the global genotyping assay market in terms of revenue, with about 40% share, in 2018. Growing incidences of genetic disorders, technological advancements, the presence of major players, increasing the need for personalized medicines, and decreasing costs of DNA sequencing are some factors driving the North American genotyping assay market. The second largest region in the global genotyping assay market in 2018 was Europe, due to increasing investments made by private and public companies and the presence of robust healthcare infrastructure. The Asia Pacific genotyping assay market is estimated to show the highest CAGR over the forecast time period, owing to the flourishing pharmaceutical and biopharmaceutical industry, increasing geriatric population, rising health awareness, and growing research and development activities in developing nations, such as China, India etc.
Request Free Sample Report @ https://www.zionmarketresearch.com/sample/genotyping-assay-market
Some key players of the global genotyping assay market include Thermo Fisher Scientific, Inc., Illumina, Inc., Roche Diagnostics Limited, Danaher Corporation, Qiagen N.V., Fluidigm Corporation, Agilent Technologies, Inc., GE Healthcare, Integrated DNA Technologies, Inc., Genewiz, Inc., Perkinelmer, Inc., Bio-Rad Laboratories, Inc., Pacific Biosciences of California, Inc., and Eurofins Scientific.
This report segments the global genotyping assay market into:
Global Genotyping Assay Market: By Products and Services
Reagents and Kits
Genotyping Services
Instruments
Sequencers and Amplifiers
Analyzers
Bioinformatics
Software
Services
Global Genotyping Assay Market: By Technology
Polymerase Chain Reaction
Real-Time PCR
Digital PCR
Microarrays
Sequencing
Next-Generation Sequencing
Pyrosequencing
Sanger Sequencing
Capillary Electrophoresis
Amplified Fragment Length Polymorphism
Restriction Fragment Length Polymorphism
Single-Strand Conformation Polymorphism
Matrix-Assisted Laser Desorption/Ionization-Time of Flight (MALDI-Tof) Mass Spectrometry
Others
Global Genotyping Assay Market: By Application
Pharmacogenomics
Diagnostics and Personalized Medicine
Animal Genetics
Agricultural Biotechnology
Others
Global Genotyping Assay Market: By End-User
Pharmaceutical & Biopharmaceutical Companies
Diagnostic & Research Laboratories
Academic Institutes
Others
Inquiry more about this report @ https://www.zionmarketresearch.com/inquiry/genotyping-assay-market
Global Genotyping Assay Market: By Region
North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
The Middle East and Africa
Global Genotyping Assay Market Is Anticipated to Reach Around USD 46.9 Billion by 2025
Global genotyping assay market expected to generate around USD 46.9 billion by 2025, at a CAGR of around 21.8% between 2019 and 2025. Genotyping is a technology used to identify genetic variation in the genomic sequence or allelic genes of an individual by comparing it against the reference sequence.